APA (7th ed.) Citation

Burke, T., Torres, R., McNulty, A., Dempsey, J., Kolis, S., Kulanthaivel, P., & Beckmann, R. (2016). Abstract 2830: The major human metabolites of abemaciclib are inhibitors of CDK4 and CDK6. Cancer research (Chicago, Ill.), 76(14_Supplement), 2830. https://doi.org/10.1158/1538-7445.AM2016-2830

Chicago Style (17th ed.) Citation

Burke, Teresa, Raquel Torres, Ann McNulty, Jack Dempsey, Stanley Kolis, Palaniappan Kulanthaivel, and Richard Beckmann. "Abstract 2830: The Major Human Metabolites of Abemaciclib Are Inhibitors of CDK4 and CDK6." Cancer Research (Chicago, Ill.) 76, no. 14_Supplement (2016): 2830. https://doi.org/10.1158/1538-7445.AM2016-2830.

MLA (9th ed.) Citation

Burke, Teresa, et al. "Abstract 2830: The Major Human Metabolites of Abemaciclib Are Inhibitors of CDK4 and CDK6." Cancer Research (Chicago, Ill.), vol. 76, no. 14_Supplement, 2016, p. 2830, https://doi.org/10.1158/1538-7445.AM2016-2830.